中文 | English
Return
Total: 226 , 1/23
Show Home Prev Next End page: GO
Author:(Zhigang WEI)

1.Clinical Study of Cyclosporin A for Psoriasis in China.

Liao WANQUNG ; Li ZHIGANG ; Hong WEI

Annals of Dermatology 1995;7(4):313-317

2.Correlation between G919A polymorphism of cystathionine β synthase and breast cancer in Han nationality in Xinjiang

Wei ZHANG ; Lei ZHANG ; Zhigang LI

The Journal of Practical Medicine 2016;32(3):382-384

3.Association of serum visceral adipose tissue-derived serine protease inhibitor levels with carotid atherosclerosis in elderly patients with type 2 diabetes

Wei XIA ; Zhigang ZHAO ; Huifeng ZHANG

Chinese Journal of General Practitioners 2011;10(9):670-672

4.Regeneration of rat sciatic nerve inhanced by chemical acellular xenogeneous nerve grafts:a functional evaluation

Zhigang ZHAO ; Bingyao CHEN ; Haiwen WEI

Orthopedic Journal of China 2006;0(12):-

5.Establishment of detecting methods of Th1/Th2 cytokine gene

Jie LIU ; Haiming WEI ; Zhigang TIAN

Chinese Journal of Immunology 1999;0(12):-

6.The gene expression of cytokines in human tumor cell lines and specimens

Haiming WEI ; Zhigang TIAN ; Jinbo FENG

Chinese Journal of Immunology 2000;0(08):-

7.Pretreatment with a low dose of concanavalin A attenuated the development of concanavalin A-induced hepatitis

Xu XU ; Haiming WEI ; Zhigang TIAN

Chinese Journal of Immunology 2000;0(08):-

8.Study of the Effects of Melagenine on Melanocyte Proliferation and Malanin Synthesis

Aie XU ; Xiaodong WEI ; Zhigang BI

Chinese Journal of Dermatology 1995;0(01):-

9.Clinical observation on 40 cases of primary glomerular hemataria treated with Xue Niao Tai

Lianbo WEI ; Zhigang MA ; Tu LUAN

Journal of Traditional Chinese Medicine 1992;0(08):-

10.miR-let-7d regulates lung cancer cell proliferation and invasion abilities through nuclear receptor PPARγ

Jiateng ZHONG ; Zhigang GUO ; Wei SU

Chinese Journal of Pathophysiology 2017;33(4):699-704

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 226 , 1/23 Show Home Prev Next End page: GO